Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Revenue | — | 58M |
| Cost of revenue | — | 48M |
| Gross profit | — | 10M |
| Research and development | — | 14M |
| Selling, general and administrative | 5M | 12M |
| Operating expenses | 5M | 44M |
| Operating income | −5M | −34M |
| Pre-tax income | −8M | −33M |
| Income tax | — | 226,000 |
| Net income | −21M | −34M |
| Earnings per share | −28.58 | −7.13 |
| Earnings per share, diluted | −28.58 | −7.13 |
| Weighted average shares | 722,689 | 5M |
| Weighted average shares, diluted | 722,689 | 5M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1M | 1M | 2M | 2M | 2M | 5M | 9M | 10M |
| Receivables | 2M | — | 3M |
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Operating cash flow | −24M | −8M |
| Depreciation and amortisation | 4M | 4M |
| Share-based compensation | 2M | 2M |
| Capital expenditure | — | 214,000 |
| Investing cash flow | — | −214,000 |
| Financing cash flow |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 3M |
| 5M |
| 4M |
| 5M |
| 8M |
| Inventory | — | — | 11M | 10M | 9M | 11M | 12M | 7M |
| Current assets | 3M | 29M | 30M | 27M | 27M | 32M | 34M | 33M |
| Property, plant and equipment | — | — | 140,000 | 161,000 | 188,000 | 227,000 | 239,000 | 120,000 |
| Total assets | 5M | 44M | 40M | 36M | 36M | 40M | 49M | 46M |
| Current liabilities | 4M | 51M | 39M | 36M | 35M | 44M | 32M | 27M |
| Total liabilities | 5M | 51M | 41M | 37M | 37M | 45M | 34M | 28M |
| Equity | −983,000 | −8M | −701,000 | −1M | −1M | −6M | 15M | 17M |
| Shares outstanding | 1M | 1M | 1M | 10M | 6M | 276,881 | 5M | 5M |
| Shares issued | 1M | 1M | 1M | 10M | 6M | 276,881 | 5M | 5M |
| 19M |
| 5M |